---
figid: PMC5349920__oncotarget-07-86374-g008
figtitle: 'Re-purposing of curcumin as an anti-metastatic agent for the treatment
  of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian
  cancer spheroids'
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
- Mus musculus
- Human immunodeficiency virus 1
- Curcuma longa
- Dictyostelium discoideum
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5349920
filename: oncotarget-07-86374-g008.jpg
figlink: /pmc/articles/PMC5349920/figure/F8/
number: F8
caption: 'Curcumin inhibits the activities of Akt/mTOR, ERK1/1, leading to induction
  of autophagy, while ROS production is rendered by curcumin, resulting in activation
  of apoptotic signaling []. Taken together, curcumin exerts inhibition of ovarian
  cancer cell proliferation. Curcumin reduces the stemness of ovarian cancer cells
  through downregulation of Wnt/β-catenin [], Sonic Hedgehog [] and Notch pathways
  []. Curcumin inhibits the adhesion and invasion of ovarian cancer cells to peritoneal
  mesothelial lines via inhibition of NFκβ signaling activation []. Akt (pathway):
  a serine/threonine kinase involving cell survival and growth; ROS/RNS: Reactive
  Oxygen Species and Reactive Nitrogen Species; Wnt/β-catenin: a group of signal transduction
  pathways associated with tumour development; NFκβ: nuclear factor κ beta.'
papertitle: 'Re-purposing of curcumin as an anti-metastatic agent for the treatment
  of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian
  cancer spheroids.'
reftext: Misi He, et al. Oncotarget. 2016 Dec 27;7(52):86374-86387.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5104433
figid_alias: PMC5349920__F8
figtype: Figure
redirect_from: /figures/PMC5349920__F8
ndex: f2141863-df37-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5349920__oncotarget-07-86374-g008.html
  '@type': Dataset
  description: 'Curcumin inhibits the activities of Akt/mTOR, ERK1/1, leading to induction
    of autophagy, while ROS production is rendered by curcumin, resulting in activation
    of apoptotic signaling []. Taken together, curcumin exerts inhibition of ovarian
    cancer cell proliferation. Curcumin reduces the stemness of ovarian cancer cells
    through downregulation of Wnt/β-catenin [], Sonic Hedgehog [] and Notch pathways
    []. Curcumin inhibits the adhesion and invasion of ovarian cancer cells to peritoneal
    mesothelial lines via inhibition of NFκβ signaling activation []. Akt (pathway):
    a serine/threonine kinase involving cell survival and growth; ROS/RNS: Reactive
    Oxygen Species and Reactive Nitrogen Species; Wnt/β-catenin: a group of signal
    transduction pathways associated with tumour development; NFκβ: nuclear factor
    κ beta.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - FAM20C
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - DHH
  - IHH
  - SHH
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - Mtor
  - Tor
  - Akt
  - rl
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - .na.character
  - Dif
  - dl
  - Rel
  - Curcumin
  - Cancer
---
